180 related articles for article (PubMed ID: 12177619)
21. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.
Eck M; Schmausser B; Scheller K; Toksoy A; Kraus M; Menzel T; Müller-Hermelink HK; Gillitzer R
Clin Exp Immunol; 2000 Nov; 122(2):192-9. PubMed ID: 11091274
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
23. MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions.
Spandau U; Toksoy A; Goebeler M; Bröcker EB; Gillitzer R
J Invest Dermatol; 1998 Dec; 111(6):1003-9. PubMed ID: 9856808
[TBL] [Abstract][Full Text] [Related]
24. Donor-derived IP-10 initiates development of acute allograft rejection.
Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
[TBL] [Abstract][Full Text] [Related]
25. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
26. Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allografts.
Abe T; Su CA; Iida S; Baldwin WM; Nonomura N; Takahara S; Fairchild RL
Am J Transplant; 2014 Aug; 14(8):1753-64. PubMed ID: 25040187
[TBL] [Abstract][Full Text] [Related]
27. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
[TBL] [Abstract][Full Text] [Related]
28. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
[TBL] [Abstract][Full Text] [Related]
29. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
30. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
Tomura M; Nakatani I; Murachi M; Tai XG; Toyo-oka K; Fujiwara H
Transplantation; 1997 Sep; 64(5):757-63. PubMed ID: 9311716
[TBL] [Abstract][Full Text] [Related]
31. CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.
Rosenblum JM; Shimoda N; Schenk AD; Zhang H; Kish DD; Keslar K; Farber JM; Fairchild RL
J Immunol; 2010 Apr; 184(7):3450-60. PubMed ID: 20194716
[TBL] [Abstract][Full Text] [Related]
32. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
Krulová M; Zajícová A; Fric J; Holán V
Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
[TBL] [Abstract][Full Text] [Related]
33. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
34. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.
Hattori Y; Bucy RP; Kubota Y; Baldwin WM; Fairchild RL
Am J Transplant; 2012 Aug; 12(8):2017-28. PubMed ID: 22578247
[TBL] [Abstract][Full Text] [Related]
35. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
[TBL] [Abstract][Full Text] [Related]
36. T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts.
Kondo T; Watarai Y; Novick AC; Toma H; Fairchild RL
Transplantation; 1997 Mar; 63(5):732-42. PubMed ID: 9075847
[TBL] [Abstract][Full Text] [Related]
37. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
38. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
39. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
[TBL] [Abstract][Full Text] [Related]
40. Role of regulated upon activation normal T-cell expressed and secreted in a model of retransplantation acute rejection mediated by alloreactive memory CD4+ T cells.
Zhou X; Shan Z; Liang H; Lin Z; Qiu S; Kuang F; Zhuang J; Qi Z
Transplant Proc; 2013 Mar; 45(2):546-51. PubMed ID: 23498790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
